A Taiwan-made vaccine for the H7N9 strain of avian flu is expected to begin mass production in June this year after completing human trials, Taichung-based Adimmune Corp. said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
KMT caucus whip heads to Beijing to discuss cross-strait ties
04/26/2024 06:24 PM - Sports
Rakuten Monkeys' renovated stadium opener postponed due to rain
04/26/2024 05:57 PM - Business
Gaming console industry gives Taiwan huge business opportunities: Tsai
04/26/2024 05:48 PM - Business
Taiwan's 2024 GDP growth forecast raised to 3.29% due to AI boom
04/26/2024 04:55 PM - Politics
Visiting Ukrainian NGOs call for more support from Taiwan
04/26/2024 04:48 PM